Baylor Research Institute
Clinical trials sponsored by Baylor Research Institute, explained in plain language.
-
Could a drug combo stop liver cancer from coming back after transplant?
Disease control ENROLLING_BY_INVITATIONThis study looks at whether a drug called everolimus can help prevent liver cancer from returning in people who have had a liver transplant for a type of liver cancer that is harder to treat. About 336 adults who are at high risk for their cancer coming back will be randomly assi…
Phase: PHASE4 • Sponsor: Baylor Research Institute • Aim: Disease control
Last updated May 17, 2026 08:02 UTC
-
Curcumin cervical cancer trial pulled before start
Disease control TerminatedThis study planned to test whether curcumin, a natural compound found in turmeric, could safely help shrink or eliminate high-grade cervical precancerous lesions (CIN3) in women. It aimed to enroll women aged 21 and older with confirmed CIN3 and give them oral curcumin for 12 wee…
Phase: EARLY_PHASE1 • Sponsor: Baylor Research Institute • Aim: Disease control
Last updated May 17, 2026 08:02 UTC
-
Lifestyle makeover after stroke: new study tests weight loss program
Disease control OngoingThis study tests a healthy lifestyle program designed for people who have had a stroke. The program focuses on weight loss and increasing physical activity. Researchers will track 65 participants for 12 months to see if the program helps them achieve lasting health improvements.
Phase: NA • Sponsor: Baylor Research Institute • Aim: Disease control
Last updated May 17, 2026 07:59 UTC
-
Could a simple shot replace IV blood thinners in lung machine patients?
Disease control OngoingThis study compares two ways of giving the blood thinner heparin to adults on a heart-lung machine (ECMO) for severe breathing problems. One group gets the standard IV drip, the other gets a shot under the skin. Researchers will check for bleeding, dangerous clots, and survival. …
Phase: PHASE4 • Sponsor: Baylor Research Institute • Aim: Disease control
Last updated May 17, 2026 07:57 UTC
-
New painkiller could replace opioids after skin cancer surgery
Symptom relief ENROLLING_BY_INVITATIONThis study tests if a new non-opioid painkiller (suzetrigine) works as well as a standard opioid for pain after Mohs skin cancer surgery. About 75 adults having Mohs surgery will receive either suzetrigine or hydrocodone/acetaminophen. The goal is to see if the non-opioid option …
Phase: PHASE4 • Sponsor: Baylor Research Institute • Aim: Symptom relief
Last updated May 17, 2026 07:58 UTC
-
Which numbing drug works best for hernia surgery pain?
Symptom relief ENROLLING_BY_INVITATIONThis study compares two numbing medications—BDE and Exparel—to see which one helps hernia surgery patients feel less pain and use fewer painkillers. About 128 adults having abdominal wall reconstruction will take part. The goal is to find the best way to manage pain, shorten hosp…
Phase: PHASE2 • Sponsor: Baylor Research Institute • Aim: Symptom relief
Last updated May 17, 2026 07:58 UTC
-
Community health workers trained to bridge mental health gap
Knowledge-focused ENROLLING_BY_INVITATIONThis study aims to improve mental health care access for minority communities by training students from underrepresented backgrounds to become certified community health workers (CHWs). About 1500 students will receive training and internship opportunities to address mental healt…
Phase: NA • Sponsor: Baylor Research Institute • Aim: Knowledge-focused
Last updated May 17, 2026 08:01 UTC